Chronic obstructive pulmonary disease (COPD) and lung cancer are closely related disease states, and both are caused by smoking.
Patients with airflow obstruction have a much greater likelihood of having lung cancer than those with normal airflow, with all other risk factors being equal.
Heavy smokers with airflow obstruction should be monitored for the presence of lung cancer by annual chest x-rays and sputum cytology.
When the cancer can be detected early (i.e. in situ or stage I), the cure rate equals that of many other cancers.
It is time to abandon the incorrect notion that lung cancer screening is futile ; patients at highest risk are candidates for the same kind of cancer surveillance as are patients at risk of breast, prostate, uterine, and colon cancers.
Mots-clés Pascal : Tumeur maligne, Bronchopulmonaire, Homme, Bronchopneumopathie obstructive, Chronique, Tabagisme, Etats Unis, Amérique du Nord, Amérique, Epidémiologie, Association morbide, Dépistage, Appareil respiratoire pathologie, Poumon pathologie, Bronche pathologie
Mots-clés Pascal anglais : Malignant tumor, Bronchopulmonary, Human, Obstructive pulmonary disease, Chronic, Tobacco smoking, United States, North America, America, Epidemiology, Concomitant disease, Medical screening, Respiratory disease, Lung disease, Bronchus disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0408643
Code Inist : 002B11A. Création : 19/12/1997.